中国中医药信息杂志
中國中醫藥信息雜誌
중국중의약신식잡지
CHINESE JOURNAL OF INFORMATION ON TRADITIONAL CHINESE MEDICINE
2013年
9期
16-17,18
,共3页
买买提依力·努尔买提%海如拉·木萨%吐尔洪·阿西木%艾尼瓦尔·塔力甫
買買提依力·努爾買提%海如拉·木薩%吐爾洪·阿西木%艾尼瓦爾·塔力甫
매매제의력·노이매제%해여랍·목살%토이홍·아서목%애니와이·탑력보
维吾尔医药%失眠症%回顾性调查%用药分析
維吾爾醫藥%失眠癥%迴顧性調查%用藥分析
유오이의약%실면증%회고성조사%용약분석
Uygur medicine%insomnia%retrospective investigation%analysis of drug use
目的回顾性分析维吾尔医药治疗失眠症的用药特点及临床效果。方法通过医院信息病历统计系统,选取诊断为失眠症的234例住院病历,对患者一般情况、维吾尔药使用率、合并用药、致病体液、疗程及治疗效果等进行回顾性分析。结果失眠患者的年龄主要分布在30~60岁之间,占81.82%;异常黑胆质和黏液质为主要致病体液,分别占54.27%、28.63%。所涉及制剂品种85种,其中益脑吾斯提库都斯糖浆使用频次为213次,使用率91.03%;木尼孜其赛吾达合剂使用频次为163次,使用率69.66%;5~12种制剂合并使用的病历数最多,占89.13%;用药天数在7~30 d的病例数占总数的73.16%。结论维吾尔医药治疗失眠症用药独特,具有良好的临床疗效和安全性。
目的迴顧性分析維吾爾醫藥治療失眠癥的用藥特點及臨床效果。方法通過醫院信息病歷統計繫統,選取診斷為失眠癥的234例住院病歷,對患者一般情況、維吾爾藥使用率、閤併用藥、緻病體液、療程及治療效果等進行迴顧性分析。結果失眠患者的年齡主要分佈在30~60歲之間,佔81.82%;異常黑膽質和黏液質為主要緻病體液,分彆佔54.27%、28.63%。所涉及製劑品種85種,其中益腦吾斯提庫都斯糖漿使用頻次為213次,使用率91.03%;木尼孜其賽吾達閤劑使用頻次為163次,使用率69.66%;5~12種製劑閤併使用的病歷數最多,佔89.13%;用藥天數在7~30 d的病例數佔總數的73.16%。結論維吾爾醫藥治療失眠癥用藥獨特,具有良好的臨床療效和安全性。
목적회고성분석유오이의약치료실면증적용약특점급림상효과。방법통과의원신식병력통계계통,선취진단위실면증적234례주원병력,대환자일반정황、유오이약사용솔、합병용약、치병체액、료정급치료효과등진행회고성분석。결과실면환자적년령주요분포재30~60세지간,점81.82%;이상흑담질화점액질위주요치병체액,분별점54.27%、28.63%。소섭급제제품충85충,기중익뇌오사제고도사당장사용빈차위213차,사용솔91.03%;목니자기새오체합제사용빈차위163차,사용솔69.66%;5~12충제제합병사용적병력수최다,점89.13%;용약천수재7~30 d적병례수점총수적73.16%。결론유오이의약치료실면증용약독특,구유량호적림상료효화안전성。
Objective To retrospective analyze the drug characteristic and clinical effect of Uygur medicine for treating insomnia. Methods Totally 234 cases of insomnia in hospitalized records were selected by record statistical system of HIS. Patients’ general conditions, Uygur medicine utilization rate, combination medication, pathogenic humoral, treatment course and therapeutic effect were retrospectively analyzed. Results Insomnia patients were mainly 30-60 years old (81.82%). Abnormal Sawda and Balgam were the main pathogenic humoral, accounted for 54.27% and 28.63% respectively. And 85 kinds of preparation were involved, including Yinao Wusiti Kudousi syrup and Muniziqii Sawda mixture, 213 and 163 times of frequency (91.03% and 69.66%) respectively. Most of patients used 5-12 kinds of preparation, accounted for 89.13%, and treated for one week to one month, accounted for 73.16%. Conclusion The Uygur medicine for insomnia is unique, and has good clinical efficacy and safety.